| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.41 | 0.003 |